ANDA 40502, held by Impax Labs. Pyridostigmine Bromide.
As of Nov 16, 2026, ANDA 40502 (Pyridostigmine Bromide), held by Impax Labs, was first approved by FDA on Apr 24, 2003, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 24, 2003 | Original application | Approved | None posted |
| Pyridostigmine Bromide60MG · tablet;oral | Pyridostigmine Bromide | Rx |
| Pyridostigmine Bromide30MG · tablet;oral | Pyridostigmine Bromide | Rx |
| Oct 28, 2010 | Supplement 3Labeling | Approved | None posted |
| Apr 24, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters